publication venue for
- FDA approval of benzgalantamine exposes flaws in the 505(b)(2) pathway for innovations on existing drugs. 2026
- Potential risks of GenAI on medical education.. 30:406-408. 2025
- Expanded disease definitions in Alzheimer's disease and the new era of disease-modifying drugs.. 30:288-290. 2025
- Potential risks of GenAI on medical education.. 30:406-408. 2025
- Potential impact of large language models on academic writing.. 29:201-202. 2024
- Potential impact of large language models on academic writing.. 29:201-202. 2024
- Promise and peril of claims-based dementia ascertainment in causal inference.. 28:222-225. 2023
- US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics.. 28:151-156. 2023
- Consistency between trials presented at conferences, their subsequent publications and press releases.. 28:95-102. 2022
- Association of study design features and treatment effects in trials of chronic medical conditions: a meta-epidemiological study.. 27:104-108. 2021
- Digital medicine systems: an evergreening strategy or an advance in medication management?. 24:203-204. 2019
- Make quotations great again: a proposal to reduce false-knowledge.. 25:12-14. 2019
- Evidence maps: a tool to guide research agenda setting.. 24:209-211. 2019
- AI in healthcare: an introduction for clinicians.. 30:376-380.
- Consistency between trials presented at conferences, their subsequent publications and press releases 2023
- Consistency between trials presented at conferences, their subsequent publications and press releases 2022